Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03071913 · ClinicalTrials.gov registry record
Blood Brain Barrier Differences in Patients with Brain Tumors Undergoing Surgery
A clinical trial of Metastatic Malignant Neoplasm in the Brain and Recurrent Brain Neoplasm, sponsored by Mayo Clinic.
- Completed
- Registry status
- 54
- Enrollment target
- 1
- Study location
NCT03071913 is a study of Metastatic Malignant Neoplasm in the Brain and Recurrent Brain Neoplasm that has completed, run by Mayo Clinic. The registered enrollment target is 54 participants, below the 87-participant average among 43 other Metastatic Malignant Neoplasm in the Brain trials with a reported enrollment target (38% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03071913, a study of Metastatic Malignant Neoplasm in the Brain and Recurrent Brain Neoplasm, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 54 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot research trial studies blood brain barrier differences in patients with brain tumors undergoing surgery. Studying samples of tissue and blood from patients with brain tumors in the laboratory may help doctors to understand how well drugs get into different parts of a brain tumor. This may help them to determine which types of drugs may be best for treating brain tumors.
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Laboratory Biomarker Analysis
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2017-09-20 |
| Est. Completion | 2023-01-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03071913
The ClinicalTrials.gov registry entry for NCT03071913 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 87-participant average among 43 other Metastatic Malignant Neoplasm in the Brain trials with a reported enrollment target (38% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Metastatic Malignant Neoplasm in the Brain appearing as the primary indexed condition, and to 2 interventions - of which Biospecimen Collection is the first listed.
NCT03071913 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT03071913 about?
NCT03071913 is a clinical study titled "Blood Brain Barrier Differences in Patients with Brain Tumors Undergoing Surgery". This pilot research trial studies blood brain barrier differences in patients with brain tumors undergoing surgery. Studying samples of tissue and blood from patients with brain tumors in the laboratory may help doctors to understand how well drugs get into different parts of a brain tumor. This may...
What is the current status of trial NCT03071913?
This trial is currently completed. The enrollment target is 54 participants. The study started on 2017-09-20. Estimated completion is 2023-01-12.
What conditions does trial NCT03071913 study?
This clinical trial studies the following conditions: Metastatic Malignant Neoplasm in the Brain, Recurrent Brain Neoplasm, Central Nervous System Neoplasm, Localized Brain Neoplasm.
What interventions are being tested in trial NCT03071913?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Laboratory Biomarker Analysis (OTHER).
Who is sponsoring clinical trial NCT03071913?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03071913 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metastatic Malignant Neoplasm in the Brain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pre-operative SRS or Post-operative SRS in Treating Cancer Patients With Brain Metastases
RECRUITING · Phase 3
-
Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors
RECRUITING · Phase 1
-
Patient Perceptions Around Quality of Care Through Telemedicine in Neuro-Oncology
RECRUITING
-
Advanced Magnetic Resonance Imaging for the Identification of Recurrent Brain Tumors and Radiation Necrosis
RECRUITING · NA
-
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
RECRUITING · NA
-
Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain
RECRUITING · Phase 1
Explore more on PlainTrial
Metastatic Malignant Neoplasm in the Brain
All registered trials for this condition
Recurrent Brain Neoplasm
All registered trials for this condition
Minnesota
All trials with a study site in Minnesota
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.